Pastilles overtake oil among 18-44 age group as SAS-B approvals near 2024 total by Steve Jones October 1, 2025October 1, 2025 Pastilles have overtaken oil as the second most prescribed dosage form among the 18-44 age demographic, […]
No let up for industry as health bodies continue relentless campaign against medicinal cannabis by Steve Jones October 1, 2025October 1, 2025
Cann Group granted two-week loan reprieve as refinancing talks continue by Adam Sheldon October 1, 2025October 1, 2025
Imports outpace local cultivation growth, stockpiled flower up 48% by Steve Jones October 1, 2025February 21, 2026
Patients are not being heard: it’s time to put that right by Natalie D'Alessandro September 30, 2025February 21, 2026
Failed clinical trial highlights perils of medicinal cannabis research by Adam Sheldon September 30, 2025October 1, 2025
‘Forgotten’ patients urged to make their voices heard as TGA consultation deadline looms by Steve Jones September 30, 2025February 21, 2026
News in brief: Bod medical sales up 70%; Beacon inhaler launch; Ananda Clinics to rebrand; health tech firm seeks capital for expansion by Adam Sheldon and Steve Jones September 29, 2025February 21, 2026
AMCA suspends new patient access to Compass program amid ‘comprehensive review’ by Steve Jones September 29, 2025February 21, 2026
Tributes paid to Dr Teresa Towpik as doctors gather for Medihuanna conference by Steve Jones September 25, 2025February 21, 2026
